文献速递免疫规划卫生政策与健康促进

美国成人COVID-19疫苗犹豫量表的开发与验证

Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States.
PubMed 文献 · Vaccine · 2022-08-31

本研究开发了一种用于测量美国成人COVID-19疫苗犹豫的10条目新工具,通过亚马逊Mechanical Turk在线平台招募232名参与者。量表内部一致性(Cronbach's α=0.89)和重测信度(r=0.87;p<0.001)良好。较低的犹豫(高分)与对医生的信任度较高相关(r=0.58;p<0.001),较高的犹豫(低分)与阴谋论信念较高相关(r=-0.68;p<0.001)。低犹豫与报告接种至少一剂COVID-19疫苗的意愿(或接种史)呈中-强相关(r=0.68;p<0.001)。

要点

  • 开发了10条目COVID-19疫苗犹豫量表,内部一致性Cronbach's α=0.89,重测信度r=0.87(p<0.001)。
  • 较低犹豫(高分)与对医生信任度较高相关(r=0.58;p<0.001)。
  • 较高犹豫(低分)与阴谋论信念较高相关(r=-0.68;p<0.001)。

核心结论

  • 开发并验证了一种用于测量美国成人COVID-19疫苗犹豫的10条目量表,信效度良好,并与信任度和阴谋论信念相关。

研究设计与样本

  • 通过亚马逊Mechanical Turk在线众包平台招募232名参与者,开发并验证10条目COVID-19疫苗犹豫量表。

主要发现

  • 量表内部一致性Cronbach's α=0.89,重测信度r=0.87(p<0.001)。
  • 较低犹豫(高分)与对医生信任度较高相关(r=0.58;p<0.001)。
  • 较高犹豫(低分)与阴谋论信念较高相关(r=-0.68;p<0.001)。
  • 低犹豫与报告接种至少一剂COVID-19疫苗的意愿(或接种史)呈中-强相关(r=0.68;p<0.001)。

关键数值与推荐

  • 量表共10个条目,用于测量美国成人COVID-19疫苗犹豫。
  • 内部一致性Cronbach's α=0.89;重测信度r=0.87(p<0.001)。
  • 与对医生信任度相关r=0.58(p<0.001);与阴谋论信念相关r=-0.68(p<0.001)。
  • 与接种至少一剂COVID-19疫苗的意愿(或接种史)相关r=0.68(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19 vaccines have been rapidly developed. However, widespread uptake remains a hurdle to a successful pandemic response. A simple, user-friendly survey to measure vaccine hesitancy may facilitate development of interventions aimed at maximizing vaccination. We developed a novel 10-item instrument designed to measure COVID-19 vaccine hesitancy in adults in the United States. We recruited 232 participants through Amazon's Mechanical Turk, an online crowdsourcing platform. The internal consistency (Cronbach's α = 0.89) and temporal stability (r = 0.87; p < 0.001) of our survey was strong. Lower hesitancy (high scores) was associated with higher trust in physicians (r = 0.58; p < 0.001), and higher hesitancy (low scores) was reported with higher belief in conspiracies (r = -0.68; p < 0.001). The correlation between low hesitancy and reported intent to receive (or history of receiving) at least one dose of the COVID-19 vaccine was moderate-strong (r = 0.68; p < 0.001).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hrin ML, Emmerich VK, Ip EH, et al. Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States. Vaccine. 2022. PMID: 36058793. doi:10.1016/j.vaccine.2022.08.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。